Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer

Breast Cancer Research

Volumn 10, Issue 2, 2008, Pages

  Mitra, Aparna ^a   Fillmore, Rebecca A ^a   Metge, Brandon J ^a   Rajesh, Mathur ^a   Xi, Yaguang ^a   King, Judy ^b   Ju, Jingfang ^a   Pannell, Lewis ^a   Shevde, Lalita A ^a   Samant, Rajeev S ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; COMPLEMENTARY DNA; DNAJB6 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 40; ISOPROTEIN; KISS1 PROTEIN, HUMAN; NERVE PROTEIN; RNA; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; ARTICLE; BREAST TUMOR; CANCER INVASION; CELL MOTION; CONFOCAL MICROSCOPY; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOBLOTTING; METABOLISM; MICROARRAY ANALYSIS; MOUSE; NUDE MOUSE; PAGET NIPPLE DISEASE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP40 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOBLOTTING; MICE; MICE, NUDE; MICROARRAY ANALYSIS; MICROSCOPY, CONFOCAL; MOLECULAR CHAPERONES; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; WOUND HEALING;

EID: 48949119506     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1874     Document Type: Article

References (51)

1. Ohtsuka K, Hata M. Mammalian HSP40/DNAJ homologs: cloning of novel cDNAs and a proposal for their classification and nomenclature. Cell Stress Chaperones 2000, 5:98-112. 312896, 11147971, 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2.
2. Seki N, Hattori A, Hayashi A, Kozuma S, Miyajima N, Saito T. Cloning, tissue expression, and chromosomal assignment of human MRJ gene for a member of the DNAJ protein family. J Hum Genet 1999, 44:185-189. 10.1007/s100380050139, 10319584.
3. http://www.ncbi.nlm.nih.gov/sites/gquery?itool=toolbar
4. Hunter PJ, Swanson BJ, Haendel MA, Lyons GE, Cross JC. Mrj encodes a DnaJ-related co-chaperone that is essential for murine placental development. Development 1999, 126:1247-1258.
5. Chuang JZ, Zhou H, Zhu M, Li SH, Li XJ, Sung CH. Characterization of a brain-enriched chaperone, MRJ, that inhibits Huntingtin aggregation and toxicity independently. J Biol Chem 2002, 277:19831-19838. 10.1074/jbc.M109613200, 11896048.
6. Fayazi Z, Ghosh S, Marion S, Bao X, Shero M, Kazemi-Esfarjani P. A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation. Neurobiol Dis 2006, 24:226-244. 10.1016/j.nbd.2006.06.015, 16934481.
7. Izawa I, Nishizawa M, Ohtakara K, Ohtsuka K, Inada H, Inagaki M. Identification of Mrj, a DnaJ/Hsp40 family protein, as a keratin 8/18 filament regulatory protein. J Biol Chem 2000, 275:34521-34527. 10.1074/jbc.M003492200, 10954706.
8. Dai YS, Xu J, Molkentin JD. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment. Mol Cell Biol 2005, 25:9936-9948. 1280278, 16260608, 10.1128/MCB.25.22.9936-9948.2005.
9. Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, Leonard TO, Goldberg SF, Budgeon L, Meehan WJ, Winter CR, Christensen ND, Verderame MF, Donahue HJ, Welch DR. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clin Exp Metastasis 2000, 18:683-693. 10.1023/A:1013124725690, 11827072.
10. Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN, Wolman SR, Heppner GH, Miller FR. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 2001, 65:101-110. 10.1023/A:1006461422273, 11261825.
11. Miller FR, Santner SJ, Tait L, Dawson PJ. MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst 2000, 92:1185-1186. 10.1093/jnci/92.14.1185A, 10904098.
12. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990, 50:717-721.
13. Ellison G, Klinowska T, Westwood RF, Docter E, French T, Fox JC. Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol 2002, 55:294-299. 1187258, 12354931, 10.1136/mp.55.5.294.
14. Sellappan S, Grijalva R, Zhou X, Yang W, Eli MB, Mills GB, Yu D. Lineage infidelity of MDA-MB-435 cells: expression of melanocyte proteins in a breast cancer cell line. Cancer Res 2004, 64:3479-3485. 10.1158/0008-5472.CAN-3299-2, 15150101.
15. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD. MDA-MB-435 cells are derived from M14 melanoma cells: a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 2007, 104:13-19. 10.1007/s10549-006-9392-8, 17004106.
16. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235. 10.1038/73432, 10700174.
17. Liby K, Neltner B, Mohamet L, Menchen L, Ben-Jonathan N. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth. Breast Cancer Res Treat 2003, 79:241-252. 10.1023/A:1023956223037, 12825859.
18. Shevde LA, Samant RS, Paik JC, Metge BJ, Chambers AF, Casey G, Frost AR, Welch DR. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clin Exp Metastasis 2006, 23:123-133. 1574364, 16830223, 10.1007/s10585-006-9013-2.
19. Sadowski HB, Gilman MZ. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature 1993, 362:79-83. 10.1038/362079a0, 7680434.
20. Mbeunkui F, Metge BJ, Shevde LA, Pannell LK. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer. J Proteome Res 2007, 6:2993-3002. 10.1021/pr060629m, 17608509.
21. Matrix Science. , http://www.matrixscience.com
22. Cheng X, Belshan M, Ratner L. Hsp40 facilitates HIV-2 Vpx-mediated preintegration complex nuclear import. J Virol 2008, 82:1229-1237. 10.1128/JVI.00540-07, 18032501.
23. PSORT II software. , http://psort.hgc.jp/
24. Sung V, Gilles C, Murray A, Clarke R, Aaron AD, Azumi N, Thompson EW. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp Cell Res 1998, 241:273-284. 10.1006/excr.1998.4029, 9637769.
25. Koblinski JE, Kaplan-Singer BR, VanOsdol SJ, Wu M, Engbring JA, Wang S, Goldsmith CM, Piper JT, Vostal JG, Harms JF, Welch DR, Kleinman HK. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res 2005, 65:7370-7377. 10.1158/0008-5472.CAN-05-0807, 16103089.
26. Syken J, De-Medina T, Munger K. TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions. Proc Natl Acad Sci USA 1999, 96:8499-8504. 17545, 10411904, 10.1073/pnas.96.15.8499.
27. Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C, Lee JD. Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells. Cancer Res 2004, 64:7732-7739. 10.1158/0008-5472.CAN-04-1323, 15520177.
28. Trentin GA, He Y, Wu DC, Tang D, Rozakis-Adcock M. Identification of a hTid-1 mutation which sensitizes gliomas to apoptosis. FEBS Lett 2004, 578:323-330. 10.1016/j.febslet.2004.11.034, 15589840.
29. Kim SW, Hayashi M, Lo JF, Fearns C, Xiang R, Lazennec G, Yang Y, Lee JD. Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8. Cancer Res 2005, 65:8784-8791. 10.1158/0008-5472.CAN-04-4422, 16204048.
30. Syken J, Macian F, Agarwal S, Rao A, Munger K. TID1, a mammalian homologue of the drosophila tumor suppressor lethal(2) tumorous imaginal discs, regulates activation-induced cell death in Th2 cells. Oncogene 2003, 22:4636-4641. 10.1038/sj.onc.1206569, 12879007.
31. Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 2006, 98:825-838.
32. Wang CC, Tsai MF, Hong TM, Chang GC, Chen CY, Yang WM, Chen JJ, Yang PC. The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion. Oncogene 2005, 24:4081-4093.
33. Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer 2004, 90:1877-1881. 10.1038/sj.bjc.6601839, 15138464.
34. Tuck AB, Chambers AF. The role of osteopontin in breast cancer: clinical and experimental studies. J Mammary Gland Biol Neoplasia 2001, 6:419-429. 10.1023/A:1014734930781, 12013531.
35. Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OL. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 1997, 3:171-176. 10.1038/nm0297-171, 9018235.
36. Porte H, Chastre E, Prevot S, Nordlinger B, Empereur S, Basset P, Chambon P, Gespach C. Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int J Cancer 1995, 64:70-75. 10.1002/ijc.2910640114, 7665251.
37. Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994, 31:325-335. 10.1007/BF00666165, 7881109.
38. Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L, Dexter T, Davies S, Bulmer K, Ford E, Parry S, Budroni M, Palmieri G, Neville AM, O'Hare MJ, Lakhani SR. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res 2004, 64:3037-3045. 10.1158/0008-5472.CAN-03-2028, 15126339.
39. Adwan H, Bauerle TJ, Berger MR. Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 2004, 11:109-120. 10.1038/sj.cgt.7700659, 14647232.
40. Campo McKnight DA, Sosnoski DM, Koblinski JE, Gay CV. Roles of osteonectin in the migration of breast cancer cells into bone. J Cell Biochem 2006, 97:288-302. 10.1002/jcb.20644, 16173048.
41. Brysk MM, Lei G, Adler-Storthz K, Chen Z, Brysk H, Tyring SK, Arany I. Zinc-alpha2-glycoprotein expression as a marker of differentiation in human oral tumors. Cancer Lett 1999, 137:117-120. 10.1016/S0304-3835(98)00347-4, 10376801.
42. Henshall SM, Horvath LG, Quinn DI, Eggleton SA, Grygiel JJ, Stricker PD, Biankin AV, Kench JG, Sutherland RL. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy. J Natl Cancer Inst 2006, 98:1420-1424.
43. Diez-Itza I, Sanchez LM, Allende MT, Vizoso F, Ruibal A, Lopez-Otin C. Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters. Eur J Cancer 1993, 29A:1256-1260. 10.1016/0959-8049(93)90068-Q, 8343263.
44. Rindi G, Licini L, Necchi V, Bottarelli L, Campanini N, Azzoni C, Favret M, Giordano G, D'Amato F, Brancia C, Solcia E, Ferri GL. Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development and increase in hyperplasia and neoplasia. J Clin Endocrinol Metab 2007, 92:2811-2815. 10.1210/jc.2007-0035, 17440014.
45. Yun JP, Miao J, Chen GG, Tian QH, Zhang CQ, Xiang J, Fu J, Lai PB. Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer 2007, 96:477-484. 10.1038/sj.bjc.6603574, 17245342.
46. SecretomeP 2.0 Server. , http://www.cbs.dtu.dk/services/SecretomeP/
47. Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 2003, 162:609-617. 1851149, 12547718.
48. Lee JH, Welch DR. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 1997, 57:2384-2387.
49. Masui T, Doi R, Mori T, Toyoda E, Koizumi M, Kami K, Ito D, Peiper SC, Broach JR, Oishi S, Niida A, Fujii N, Imamura M. Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun 2004, 315:85-92. 10.1016/j.bbrc.2004.01.021, 15013429.
50. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 2001, 276:28969-28975. 10.1074/jbc.M102743200, 11387329.
51. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 2001, 411:613-617. 10.1038/35079135, 11385580.